The Medal for Scientific Distinguishment aims at encouraging scientific competencies in the UAE. Photo for illustrative purpose only. Image Credit: COURTESY EIAST
Dubai: The Mohammed bin Rashid Academy of Scientists (MBRAS) has announced the list of finalists for the third round of the Mohammed bin Rashid Medal for Scientific Distinguishment. The five finalists include scientists and scholars who have made a significant scientific contribution.
Celebrating and encouraging scientific competencies in the UAE, the medal allows scientists to showcase their capabilities by leveraging the wide array of opportunities offered by cutting-edge technologies. This will enable them to develop vital sectors and support advanced sciences in order to come up with innovative solutions to current and future challenges and harness such solutions to serve humanity and build a better world for future generations.
The winners of the third round of the Mohammed bin Rashid Medal for Scientific Distinguishment will be announced in February 2020, and will be granted the UAE Gold Visa along with their family members.
Ultimate goal
Sarah bint Yousif Al Amiri, UAE Minister of State for Advanced Sciences, said the UAE Government seeks to provide a nurturing environment for scholars of great scientific acheivements as reflected in the vision of His Highness Sheikh Mohammed bin Rashid Al Maktoum, UAE Vice President, Prime Minister and Ruler of Dubai. She noted that the ultimate goal is to engage talents and competencies to further develop sciences and scientific research, which will also achieve the objectives of the UAE Vision 2021, the National Advanced Sciences Agenda 2031 and the UAE Centennial Plan 2071.
- Sarah bint Yousif Al Amiri, UAE Minister of State for Advanced Sciences
The Mohammed bin Rashid Medal for Scientific Distinguishment reflects the keenness of the UAE Government to create a supporting environment for advanced sciences in the UAE, and to leverage innovative ideas and capabilities in its attempt to build the future and support the countrys evolution towards a sustainable and knowledge-based economy. This can be attained by extending support to the scientific and research movement and nurturing a generation of scientists and researchers who can utilize the latest innovations in science and technology to serve society and enhance the UAEs status as a global lab for future technologies, she said.
Granting the golden visa to winners of the Mohammed bin Rashid Medal for Scientific Distinguishment paves the way towards creating a stimulating environment conducive to advancement in various scientific research and knowledge fields. The move also underpins the UAEs approach to support development efforts, attract accomplished talents, competencies and researchers and encourage them to contribute to the UAEs overall economic growth and promote its leading position as a hub for scientists, innovators and researchers, she added.
Rigorous process
The Mohammed bin Rashid Medal for Scientific Distinguishment finalists were chosen from a long list of nominees from Khalifa University, UAE University, New York Abu Dhabi University, University of Sharjah, American University of Sharjah, Gulf Medical University in Ajman and Dubai Police. The finalists were evaluated by a specialised committee that included a group of top scientists and experts from different scientific fields from the National Academies of Sciences, Engineering, and Medicine in the United States.
A panel from the Emirates Scientists Council also interviewed each of the nominees. The panel included: Sarah bint Yousif Al Amiri, UAE Minister of State for Advanced Sciences and Chairperson of the Emirates Scientists Council; Dr Arif Sultan Al Hammadi, Director and the Executive Vice President of Khalifa University of Science Technology; and Professor Dr Ghaleb Ali Al Hadrami Al Breiki, Acting Vice Chancellor for Academic Affairs & Provost of UAE University.
Strict criteria
Nomination for the Mohammed bin Rashid Medal for Scientific Distinguishment is based on a set of strict criteria. Eligible candidates must be renowned scientists whose research has had a positive impact on the UAE and is aligned with the countrys vision. They must be active members in the UAE scientific community and have showcased a recognizable commitment to the development of young scientists and researchers through knowledge transfer. They must also be experts and a reference in their scientific field, both locally and internationally.
The Mohammed bin Rashid Medal for Scientific Distinguishment covers advanced research in several scientific disciplines, like Aerospace Engineering, Agricultural Biotechnology, Biology, Chemical Engineering, Civil Engineering, Clinical Medicine, Computer and Information Sciences, Earth and Environmental Sciences, Electrical Engineering, Food Sciences, Health Sciences, Material Engineering, Mechanical Engineering, Nanotechnology, Petroleum Engineering, and Physics.
Khalifa University accounted for 35 per cent of the finalists, UAE University 26 per cent and New York Abu Dhabi University 22 per cent.
Evaluation stages
The evaluation process for the Mohammed bin Rashid Medal for Scientific Distinguishment consisted of three stages. In the first stage, registration for the submission of applications from nominees was opened, allowing UAE-based scientists to participate, as well as receiving nominations from universities and research institutions. Nominees were evaluated based on the Medals initial criteria, notably specialisation, years of experience, application of scientific output and global impact of research.
In the second stage, nominees were evaluated by an international panel consisting of leading experts by looking at the nominees global impact on their respective fields.
The third stage consisted of final interviews conducted by the Emirates Scientists Council to assess the role of the nominated scientists/researchers and their contributions to scientific research in the UAE, as well as the extent to which their contributions are aligned with the National Advanced Sciences Agenda.
The finalists
Ehab El-Saadany
Director of Advanced Power and Energy Research Centre and a professor in the Electrical Engineering and Computer Science Department at Khalifa University of Science and Technology and Adjunct Professor at the ECE Department, University of Waterloo, Canada, he is the author of more than 420 top tier international journals and conferences publications with three US patents.
Professor El-Saadany helped 26 PhD and 20 Masters students graduate and supervised over 20 Postdoctoral fellows and visiting professors. He raised over $13 million in research funds from different federal, provincial and industrial entities internationally and nationally.
Rashid K. Abu Al-Rub
He is the Chair of Aerospace Engineering Department and the Director of Digital and Additive Manufacturing Centre at Khalifa University of Science and Technology. His primary research field is the development of macro-mechanics-based constitutive models and computational tools, as well as digital design, additive manufacturing and 3D printing.
He has published one book and over 300 publications in archival journals, book chapters and conference proceedings. He is responsible for a budget of more than $30 million and was selected in 2007 among nine leading scientists in the US by National Science Foundation and Department of Energy. He is one of the members of the US National Science Foundation - International Institute for Multifunctional Materials for Energy Conversion.
Lourdes Vega
He is the Director of the Research and Innovation Centre on CO2 and Hydrogen (RICH Centre) at Khalifa University and a Professor in Chemical Engineering with academic positions in the USA (University of Southern California, Cornell University); Spain (University of Sevilla, Universitat Rovira I Virgili, National Research Council of Spain); and the UAE.
Her work has been directed towards the combination of fundamental and applied research focused on sustainable processes and products. These include recent works on new refrigerants, water treatment, removal of contaminants and CO2 capture and utilisation. She is the author of more than 200 scientific papers and five patents, and she has raised more than $50 million as principal researcher grants. She serves as an editorial board member in five scientific journals and five international conference committees.
Bassam Ali
He is the Leader of the Molecular and Genomics Laboratory and Professor of Molecular and Genetic Medicine at UAE University. His research is focused on the identification of disease genes and mutations responsible for rare recessive disorders in Arab populations, and suggesting diagnostic and treatment means. He is the author of more than 80 articles in international prestigious journals and conferences.
He is on the editorial board of several international scientific journals and an expert reviewer in several biomedical journals. He also supervises 11 PhD and seven Masters students.
Mohammed ElMoursi
A Professor in the Electrical Engineering and Computer Science Department (EECS) at Khalifa University of Science and Technology, he specialises in renewable energy integration and smart grid development. He also leads Renewable Energy Integration at the Advanced Power and Energy Centre (APEC) research theme. He has two US patents and is the author of more than 140 papers published in international journals and conferences.
More:
Gold visa for Scientific Medal winners in the UAE - Gulf News
- 001 F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent [Last Updated On: April 15th, 2010] [Originally Added On: April 15th, 2010]
- 002 F.D.A. Says Millions Got Unapproved Drugs, Should the new bioequivalence and bioanalytical guidelines for 2010, be made more stringent [Last Updated On: April 16th, 2010] [Originally Added On: April 16th, 2010]
- 003 GSK, MedTrust launch iPhone/iPad app for cancer trials [Last Updated On: June 11th, 2010] [Originally Added On: June 11th, 2010]
- 004 GSK, MedTrust launch iPhone/iPad app for cancer trials [Last Updated On: June 11th, 2010] [Originally Added On: June 11th, 2010]
- 005 22 Million Australian Cloud computing initiative to benefit life science researchers [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- 006 GE Healthcare announces SaaS Electronic Medical Records Management [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- 007 22 Million Australian Cloud computing initiative to benefit life science researchers [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- 008 GE Healthcare announces SaaS Electronic Medical Records Management [Last Updated On: June 19th, 2010] [Originally Added On: June 19th, 2010]
- 009 Stem Cell Therapy: Age of Human Cell Engineering is Born [Last Updated On: June 25th, 2010] [Originally Added On: June 25th, 2010]
- 010 Using Stem Cells Scientists Grow a Rat Lung, Humans are Next [Last Updated On: June 29th, 2010] [Originally Added On: June 29th, 2010]
- 011 How useful would be the Single-patient clinical trials for improving the hopes of Personalized medicine [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- 012 How useful would be the Single-patient clinical trials for improving the hopes of Personalized medicine [Last Updated On: August 12th, 2010] [Originally Added On: August 12th, 2010]
- 013 Life Sciences at Oracle Open World 2010 [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 014 ChIP Enrichment Analysis can speed up drug discovery [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 015 GE’s healthymagination initiative lead Smart Patient Room to improve patient safety goes live at Bassett Medical Center [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 016 The SaaS impact on solution selling for ISVs (via Inner Lining) [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 017 Oracle starts the Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 018 Life Sciences at Oracle Open World 2010 [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 019 ChIP Enrichment Analysis can speed up drug discovery [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 020 GE’s healthymagination initiative lead Smart Patient Room to improve patient safety goes live at Bassett Medical Center [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 021 The SaaS impact on solution selling for ISVs (via Inner Lining) [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 022 Oracle starts the Oracle Health Sciences Institute (OHSI), in partnership with Sun Labs [Last Updated On: October 11th, 2010] [Originally Added On: October 11th, 2010]
- 023 70% of Pharmaceutical organisations outsource at least one PV activity. This level is expected to increase to 80% by 2012 [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 024 Insurance coverage for healthcare IT software, to protect healthcare IT companies from damages inflicted by their software [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 025 India announce Heart Surgery for $1000 USD [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 026 Indian Healthcare IT market & Oracle’s presence in Indian Healthcare [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 027 70% of Pharmaceutical organisations outsource at least one PV activity. This level is expected to increase to 80% by 2012 [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 028 Insurance coverage for healthcare IT software, to protect healthcare IT companies from damages inflicted by their software [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 029 India announce Heart Surgery for $1000 USD [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 030 Indian Healthcare IT market & Oracle’s presence in Indian Healthcare [Last Updated On: November 7th, 2010] [Originally Added On: November 7th, 2010]
- 031 Harvard Medical Schools new automated safety surveillance system provides faster early warnings in the postmarket evaluation of medical device safety [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 032 SalesForce.com partner introduces CRM for clinical trial management on Force Platform [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 033 Widespread fraud in the Clinical Trial of Drugs is pervasive event in United States [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 034 Scott Stern Kellogg School of Management speaks about “New Drug Development: From Laboratory to Blockbuster to Generic,” [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 035 collaborative clinical trials management software for Central Laboratories [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 036 MNC Pharma tries to capture the $1.9 billion Indian OTC market by selling Drugs through India’s 170000 post offices [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 037 Clinical Trial and Pharmacovigilance process automation [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 038 Microsoft in Clinical Trials Management System (CTMS) and Electronic Data Capture (EDC) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 039 Oracle Business Intelligence Enteprise Edition (OBIEE) for Clinical Trial Management System (CTMS) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 040 trends in the life sciences and pharma research and development outsourcing (RDO) [Last Updated On: November 29th, 2010] [Originally Added On: November 29th, 2010]
- 041 Sanofi-Aventis ties up with Oxford Univ for oncology research in India [Last Updated On: December 17th, 2010] [Originally Added On: December 17th, 2010]
- 042 PharmaNet unveils touch screen capable data capture platform for Phase I Clinical Trials [Last Updated On: December 17th, 2010] [Originally Added On: December 17th, 2010]
- 043 Adverse Events in Hospitals- United States Department of Health Report slams current measures in US hospitals [Last Updated On: December 23rd, 2010] [Originally Added On: December 23rd, 2010]
- 044 IBM Files Application to Patent The Patent [Last Updated On: January 9th, 2011] [Originally Added On: January 9th, 2011]
- 045 How to improve R&D productivity: the pharmaceutical industry’s grand challenge [Last Updated On: February 7th, 2011] [Originally Added On: February 7th, 2011]
- 046 Clinical Trial and Pharmacovigilance process automation [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 047 Microsoft in Clinical Trials Management System (CTMS) and Electronic Data Capture (EDC) [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 048 Oracle Business Intelligence Enteprise Edition (OBIEE) for Clinical Trial Management System (CTMS) [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 049 trends in the life sciences and pharma research and development outsourcing (RDO) [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 050 Sanofi-Aventis ties up with Oxford Univ for oncology research in India [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 051 PharmaNet unveils touch screen capable data capture platform for Phase I Clinical Trials [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 052 Adverse Events in Hospitals- United States Department of Health Report slams current measures in US hospitals [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 053 IBM Files Application to Patent The Patent [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 054 How to improve R&D productivity: the pharmaceutical industry’s grand challenge [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 055 AstraZeneca Announce Real-World Evidence Data Collaboration [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 056 AstraZeneca Announce Real-World Evidence Data Collaboration [Last Updated On: February 14th, 2011] [Originally Added On: February 14th, 2011]
- 057 Medication adherence improves, When Patients Share Their Stories [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 058 Questions for the CRO [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 059 Clinical Research Sites Struggle With Increasing Trial Complexity yet most depend on, Google (or other search sites) as the primary information tool [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 060 Medication adherence improves, When Patients Share Their Stories [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 061 Questions for the CRO [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 062 Clinical Research Sites Struggle With Increasing Trial Complexity yet most depend on, Google (or other search sites) as the primary information tool [Last Updated On: March 13th, 2011] [Originally Added On: March 13th, 2011]
- 063 Law of the land can help or destroy the Pharmacovigilance system [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- 064 Law of the land can help or destroy the Pharmacovigilance system [Last Updated On: March 27th, 2011] [Originally Added On: March 27th, 2011]
- 065 Indian Government’s new dose of strong medicine to bring cheers to Foreign Pharma CEOs who cut their teeth by struggling to convince Indian pharma to change sales practices [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 066 Indian Government’s new dose of strong medicine to bring cheers to Foreign Pharma CEOs who cut their teeth by struggling to convince Indian pharma to change sales practices [Last Updated On: December 18th, 2011] [Originally Added On: December 18th, 2011]
- 067 Drug Reps Soften Their Sales Pitches, as pharma learns from Disney [Last Updated On: January 15th, 2012] [Originally Added On: January 15th, 2012]
- 068 Drug Reps Soften Their Sales Pitches, as pharma learns from Disney [Last Updated On: January 15th, 2012] [Originally Added On: January 15th, 2012]
- 069 Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center [Last Updated On: January 29th, 2012] [Originally Added On: January 29th, 2012]
- 070 Oracle Unveils Oracle® Health Sciences Omics Data Bank as Part of Oracle Health Sciences Translational Research Center [Last Updated On: January 29th, 2012] [Originally Added On: January 29th, 2012]
- 071 One Way to Teach Your Boss About Social Media [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 072 “The Banks Can Do It, Why Can’t Hospitals?” [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 073 Internet on any Display Device, or internet on TV at low cost can it transform Healthcare or Clinical Research [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 074 Is Life Sciences the New Frontier for Analytics? [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 075 Internet on any Display Device, or internet on TV at low cost can it transform Healthcare or Clinical Research [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 076 Is Life Sciences the New Frontier for Analytics? [Last Updated On: February 12th, 2012] [Originally Added On: February 12th, 2012]
- 077 bluebird bio Appoints David Davidson, M.D., as Chief Medical Officer [Last Updated On: February 17th, 2012] [Originally Added On: February 17th, 2012]
- 078 SOCIAL CRM and its Impact on Pharmaceutical Industry [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- 079 privacy controlled social networking to connect patients with caregivers [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]
- 080 SOCIAL CRM and its Impact on Pharmaceutical Industry [Last Updated On: February 19th, 2012] [Originally Added On: February 19th, 2012]